1. Home
  2. NVAX vs ATLC Comparison

NVAX vs ATLC Comparison

Compare NVAX & ATLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novavax Inc.

NVAX

Novavax Inc.

SELL

Current Price

$8.05

Market Cap

2.1B

Sector

Health Care

ML Signal

SELL

Logo Atlanticus Holdings Corporation

ATLC

Atlanticus Holdings Corporation

SELL

Current Price

$81.55

Market Cap

1.7B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
NVAX
ATLC
Founded
1987
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
1996
2009

Fundamental Metrics

Financial Performance
Metric
NVAX
ATLC
Price
$8.05
$81.55
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$14.11
★ $127.40
AVG Volume (30 Days)
★ 5.8M
110.3K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 309.76
24.95
EPS
N/A
★ 9.62
Revenue
$1,123,479,000.00
★ $1,968,399,000.00
Revenue This Year
N/A
$440.35
Revenue Next Year
N/A
$12.87
P/E Ratio
★ N/A
$8.67
Revenue Growth
★ 64.69
50.09
52 Week Low
$6.20
$47.50
52 Week High
$13.39
$114.34

Technical Indicators

Market Signals
Indicator
NVAX
ATLC
Relative Strength Index (RSI) 34.94 40.07
Support Level $7.48 $74.19
Resistance Level $10.64 $94.35
Average True Range (ATR) 0.71 5.82
MACD -0.23 -1.22
Stochastic Oscillator 1.09 12.14

Price Performance

Historical Comparison
NVAX
ATLC

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

About ATLC Atlanticus Holdings Corporation

Atlanticus Holdings Corp is a financial technology company powering more inclusive financial solutions for Everyday Americans. It provides technology and other support services to lenders who offer an array of financial products and services to consumers. The company's products and services are reported through two reportable segments. Credit as a Service (CaaS) offers products including private label credit cards using the Fortiva and Curae brand names as well as merchant-associated brands and Auto Finance provides purchase and/or service loans secured by automobiles from or for, and also provides floor-plan financing for, a pre-qualified network of independent automotive dealers and automotive finance companies in the buy-here, pay-here used car business.

Share on Social Networks: